2026-02-18 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, Feb. 18, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has submitted a marketing authorization application (MAA) in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its…
